• Shadowbox closes Series A Funding round with Baleon Capital

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Oct. 24, 2022 /PRNewswire/ - Shadowbox, a leading innovator in healthcare automation solutions, today announced the close of its Series A financing with Baleon Capital, an early-stage growth fund. Baleon Capital will invest...
    Read more ...

     

  • SHORELINE BIOSCIENCES ANNOUNCES APPOINTMENT OF CELL THERAPY MANUFACTURING VETERAN CHARLES CALDERARO III AS CHIEF TECHNICAL OFFICER

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Oct. 24, 2022 /PRNewswire/ - Shoreline Biosciences, Inc. , a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells utilizing its proprietary iPSC-derived natural killer cell and macrophage......
    Read more ...

     

  • Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 24, 2022 /PRNewswire/ - Gracell Biotechnologies Inc. , a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies...
    Read more ...

     

  • Amplifica Completes $11.8 Million Series A Financing to Enable Clinical Development of Lead Products to Treat Androgenic Alopecia

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Oct. 24, 2022 /PRNewswire/ - Amplifica Holdings Group, Inc. , a privately-held, clinical-stage biopharmaceutical company announced it successfully closed an $11.8 million Series A Preferred Stock financing. The company intends to use the...
    Read more ...